Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2006Journal of Translational MedicineOpen Access

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

ALAnne Marie LewisUniversity of IowaSVSheelu VargheseUniforHXHui XuHubei University of Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lewis et al. (2006) studied this question.

synapsesocial.com/papers/6a0367aaca491f8105697294https://doi.org/10.1186/1479-5876-4-48
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interleukin-1α Enhances Integrin α6β1 Expression and Metastatic Capability of Human Pancreatic Cancer2003 · 53 citations
  2. 2Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells1997 · 182 citations
  3. 3Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme1995 · 1,642 citations
  4. 4ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs2001 · 89 citations
  5. 5The role of interleukin 1 in growth and metastasis of human cancer xenografts.2006 · 293 citations